1994
DOI: 10.1161/01.cir.89.1.511
|View full text |Cite
|
Sign up to set email alerts
|

Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
73
2
8

Year Published

1995
1995
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 283 publications
(91 citation statements)
references
References 166 publications
2
73
2
8
Order By: Relevance
“…PAD primarily results in a decreased functional capacity and deterioration in quality of life and is associated with an increased risk of limb amputation, myocardial infarction, stroke, and death [4,5,15]. Twothirds to three-fourths of patients initially presenting with IC symptoms will remain stable for several years after the initial diagnosis, whereas the remaining one-third to onefourth will show progressive disease, but only 1-5 % of the PAD population will eventually undergo amputation [14]. The prevalence of comorbid coronary and cerebrovascular disease in the PAD population exceeds 50 %.…”
Section: Clinical Assessmentmentioning
confidence: 99%
See 1 more Smart Citation
“…PAD primarily results in a decreased functional capacity and deterioration in quality of life and is associated with an increased risk of limb amputation, myocardial infarction, stroke, and death [4,5,15]. Twothirds to three-fourths of patients initially presenting with IC symptoms will remain stable for several years after the initial diagnosis, whereas the remaining one-third to onefourth will show progressive disease, but only 1-5 % of the PAD population will eventually undergo amputation [14]. The prevalence of comorbid coronary and cerebrovascular disease in the PAD population exceeds 50 %.…”
Section: Clinical Assessmentmentioning
confidence: 99%
“…A literature review was performed and recommendations and quality improvement guidelines provided in the present document are based on the highest level of evidence available to date with particular focus on the field of angioplasty of the superficial femoral and popliteal arteries. For more detailed information about the strength and level of the relevant evidence, the reader is urged to refer to other collaborative standards of practice and multidisciplinary recommendations as well [2][3][4][5][12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…Anjiyoplasti sonrası erken dönemde restenoz; yaralanma yerinde akut tromboz, akımı engelleyen diseksiyon veya elastik rekoil (elastik deformasyon yetersiz ise damarın eski konumuna dönmesi) ile oluşabilir [6]. İşlem öncesi antikoagülasyon tromboz riskini azaltır, rutin olarak tüm olgulara intravenöz heparin uygulanır.…”
Section: Anjiyoplasti Sonrası Erken Veya Geç Dönemde Tekrar Daralma (unclassified
“…Elastik rekoil her anjiyoplastide hafif ya da belirgin görülebilir. Plak duvarın sadece bir duvarında yerleşik (egzantrik) ise elastik rekoil sık görülen bir durumdur, stentleme ile tedavi edilebilir [6].…”
Section: Anjiyoplasti Sonrası Erken Veya Geç Dönemde Tekrar Daralma (unclassified
“…Screening: Patients were included in this study if they had Fontaine stage II PAD defined by the following inclusion criteria: (a) a history of claudication, (b) ambulation during a graded treadmill test limited by claudication and (c) an ankle/brachial index (ABI) at rest <0.90 [7,16,17]. Patients were excluded from this study for the following conditions: (a) absence of PAD, (b) inability to obtain an ABI measure due to non-compressible vessels, (c) asymptomatic PAD (Fontaine stage I), (d) rest pain PAD (Fontaine stage III), (e) use of medications indicated for the treatment of claudication (cilostazol and pentoxifylline) within three months prior to investigation, (f) exercise tolerance limited by any disease process other than PAD, (g) end stage renal disease defined as stage 5 chronic kidney disease, (h) abnormal liver function.…”
Section: Introductionmentioning
confidence: 99%